Bonadonna G, Bajetta E
Istituto Nazionale Tumori, Milano, Italia.
Acta Haematol. 1987;78 Suppl 1:157-62. doi: 10.1159/000205923.
Non-Hodgkin's lymphomas are among the most challenging diseases to treat and their course ranges from very aggressive and rapidly fatal tumors to some of the most indolent, well-tolerated malignancies in man.